In patients with a BMI >50, the debate continues on which surgery is best to achieve weight loss and improve health. In a new study, duodenal switch is superior to gastric bypass for weight loss, but patients suffered more adverse effects.
References
Risstad, H. et al. Five-year outcomes after laparoscopic gastric bypass and laparoscopic duodenal switch in patients with body mass index of 50 to 60: a randomized clinical trial. JAMA Surg. http://dx.doi.org/10.1001/jamasurg.2014.3579.
Søvik, T. T. et al. Randomized clinical trial of laparoscopic gastric bypass versus laparoscopic duodenal switch for superobesity. Br. J. Surg. 97, 160–166 (2010).
Laurenius, A., Taha, O., Maleckas, A., Lönroth, H. & Olbers, T. Laparoscopic biliopancreatic diversion/duodenal switch or laparoscopic Roux-en-Y gastric bypass for super-obesity-weight loss versus side effects. Surg. Obes. Relat. Dis. 6, 408–414 (2010).
Søvik, T. T. et al. Establishing laparoscopic Roux-en-Y gastric bypass: perioperative outcome and characteristics of the learning curve. Obes. Surg. 19, 158–165 (2009).
Marceau, P. et al. Does bone change after biliopancreatic diversion? J. Gastrointest. Surg. 6, 690–698 (2002).
Marceau, P. et al. Long-term metabolic outcomes 5 to 20 years after biliopancreatic diversion. Obes. Surg. http://dx.doi.org/10.1007/s11695-015-1599-5.
Smith, M. D. et al. Technical factors associated with anastomotic leak after Roux en Y gastric bypass. Surg. Obes. Relat. Dis. http://dx.doi.org/10.1016/j.soard.2014.05.036 (2014).
Sánchez-Pernaute, A. et al. Single-anastomosis duodenoileal bypass with sleeve gastrectomy: metabolic improvement and weight loss in first 100 patients. Surg. Obes. Relat. Dis. 9, 731–735 (2013).
Mechanick, J. I. et al. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient—2013 update: cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery. Obesity (Silver Spring) 21 (Suppl. 1), S1–S27 (2013).
Hedberg, J. & Sundbom, M. Superior weight loss and lower HbA1c 3 years after duodenal switch compared with Roux en Y gastric bypass—a randomized controlled trial. Surg. Obes. Relat. Dis. 8, 338–343 (2012).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
G.M. has received honoraria for speaking from Boehringer Laboratories, Covidien, Ethicon Endosurgery, Gore and Olympus.
PowerPoint slides
Rights and permissions
About this article
Cite this article
Gagner, M. To bypass or switch? That is the question in obesity surgery. Nat Rev Gastroenterol Hepatol 12, 255–256 (2015). https://doi.org/10.1038/nrgastro.2015.58
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrgastro.2015.58
- Springer Nature Limited